About Diederik van der Reijt
Form D filings for NKore Biotherapeutics in 2023 list Diederik van der Reijt as director.
Diederik van der Reijt first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Diederik van der Reijt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Diederik van der Reijt works with at each company, as listed on that company's latest Form D.
NKore Biotherapeutics, LLC · Form D, Apr 13, 2023
RB
R Gregory Brophy
Chief Executive Officer and director
TR
Tracy Ryan
Executive officer and director
TB
Timothy Brahm
Director